Abstract
The authors report a case of a patient dying as a result of a myocardial infarction which was probably related to the administration of vinorelbine, the vinca alkaloid recently introduced into the treatment of non small cell bronchial cancers.
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Carcinoma, Squamous Cell / drug therapy
-
Humans
-
Lung Neoplasms / drug therapy
-
Male
-
Middle Aged
-
Myocardial Infarction / chemically induced*
-
Vinblastine / adverse effects
-
Vinblastine / analogs & derivatives*
-
Vinorelbine
Substances
-
Antineoplastic Agents
-
Vinblastine
-
Vinorelbine